<?xml version="1.0" encoding="UTF-8"?>
<fig id="fig1">
 <label>Figure 1</label>
 <caption>
  <p>Rilpivirine Inhibits ZIKV by Blocking Viral RdRp</p>
  <p>(A) Proposed rilpivirine binding site on ZIKV RdRp. ZIKV NS5 (PDB: 
   <ext-link ext-link-type="uri" xlink:href="pdb:5TMH" id="intref0010" xmlns:xlink="http://www.w3.org/1999/xlink">5TMH</ext-link>)
   <xref rid="bib15" ref-type="bibr">
    <sup>15</sup>
   </xref> contains an N-terminal methyltransferase domain (blue) and a C-terminal RdRp domain (green). Computer docking, ligand binding test, and mutagenesis analysis suggest that 14 amino acids (purple) form the potential binding site for rilpivirine. The image was produced using PyMOL. (B) 
   <italic>In vivo</italic> efficacy. Treatment of ZIKV-infected mice with rilpivirine suppressed viral replication and prevented animal death.
  </p>
 </caption>
 <graphic xlink:href="gr1_lrg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
